4//SEC Filing
Baker Mark Robert 4
Accession 0001447348-13-000010
CIK 0000835887other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 9:24 AM ET
Size
7.3 KB
Accession
0001447348-13-000010
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Purchase
Common Stock
2013-03-27$5.31/sh+500$2,655→ 160,991 total - Purchase
Common Stock
2013-03-27$5.34/sh+50$267→ 161,041 total - Purchase
Common Stock
2013-03-27$5.36/sh+100$536→ 161,141 total
Footnotes (1)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeother
Related Parties
1- filerCIK 0001331438
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 9:24 AM ET
- Size
- 7.3 KB